VolitionRX Ltd
VNRX0.680USD
+0.056+8.96%
終値 09/19, 16:00（ET）15分遅れの株価
70.71M時価総額
損失額直近12ヶ月PER
詳細情報 VolitionRX Ltd 企業名
VolitionRx Limited is a multi-national epigenetics company focused on advancing the science of epigenetics. The Company is dedicated to saving lives and improving outcomes for people and animals with life-altering diseases through earlier detection, as well as disease and treatment monitoring. Through its subsidiaries, it is developing and commercializing blood tests to help diagnose and monitor a range of diseases, including cancers and diseases associated with NETosis, such as sepsis. Its key pillars are Nu.Q Vet, Nu.Q NETs, Nu.Q Discover, Nu.Q Cancer and Capture-PCR. The Nu.Q Vet Cancer Test is commercially available as a cancer screening test in dogs. Nu.Q NETs is monitoring the immune system to save lives. Nu.Q Discover is a complete solution to profiling nucleosomes. Nu.Q Cancer monitoring disease progression, response to treatment and minimal residual disease. Capture-PCRTM is isolating and capturing circulating tumor-derived DNA from plasma samples for early cancer detection.
企業情報
企業コードVNRX
会社名VolitionRX Ltd
上場日Feb 06, 2015
最高経営責任者「CEO」Dr. Jasmine Kway
従業員数85
証券種類Ordinary Share
決算期末Feb 06
本社所在地1489 West Warm Springs Road
都市HENDERSON
証券取引所NYSE American Consolidated
国United States of America
郵便番号89014
電話番号17024251561
ウェブサイトhttps://volition.com/
企業コードVNRX
上場日Feb 06, 2015
最高経営責任者「CEO」Dr. Jasmine Kway
役員一覧
会社名
会社名/ポジション
ポジション
株式保有
変動額
Mr. Guy Archibald Innes
Mr. Guy Archibald Innes
Independent Director
Independent Director
2.88M
+2.78%
Mr. Cameron John Reynolds
Mr. Cameron John Reynolds
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
2.18M
+0.69%
Dr. Jacob Vincent Micallef
Dr. Jacob Vincent Micallef
Chief Scientific Officer
Chief Scientific Officer
456.18K
-4.51%
Mr. Terig Hughes
Mr. Terig Hughes
Chief Financial Officer, Treasurer
Chief Financial Officer, Treasurer
388.15K
+7.22%
Dr. Salvatore Thomas Butera
Dr. Salvatore Thomas Butera
Chief Executive Officer of Volition Vet
Chief Executive Officer of Volition Vet
341.11K
+8.80%
Dr. Jasmine Kway
Dr. Jasmine Kway
Chief Executive Officer of Singapore Volition
Chief Executive Officer of Singapore Volition
203.61K
+6.54%
Dr. Alan Colman, Ph.D.
Dr. Alan Colman, Ph.D.
Independent Director
Independent Director
203.55K
-10.28%
Mr. Gael Forterre
Mr. Gael Forterre
Chief Commercial Officer
Chief Commercial Officer
166.43K
+4.37%
Mr. Nicholas Plummer
Mr. Nicholas Plummer
Group General Counsel
Group General Counsel
164.38K
+13.52%
Dr. Andrew Retter
Dr. Andrew Retter
Chief Medical Officer
Chief Medical Officer
151.16K
+9.71%
詳細を見る
会社名
会社名/ポジション
ポジション
株式保有
変動額
Mr. Guy Archibald Innes
Mr. Guy Archibald Innes
Independent Director
Independent Director
2.88M
+2.78%
Mr. Cameron John Reynolds
Mr. Cameron John Reynolds
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
2.18M
+0.69%
Dr. Jacob Vincent Micallef
Dr. Jacob Vincent Micallef
Chief Scientific Officer
Chief Scientific Officer
456.18K
-4.51%
Mr. Terig Hughes
Mr. Terig Hughes
Chief Financial Officer, Treasurer
Chief Financial Officer, Treasurer
388.15K
+7.22%
Dr. Salvatore Thomas Butera
Dr. Salvatore Thomas Butera
Chief Executive Officer of Volition Vet
Chief Executive Officer of Volition Vet
341.11K
+8.80%
Dr. Jasmine Kway
Dr. Jasmine Kway
Chief Executive Officer of Singapore Volition
Chief Executive Officer of Singapore Volition
203.61K
+6.54%
収益内訳
データなし
データなし
事業別
地域別
データなし
株主
更新時刻: Sat, Aug 23
更新時刻: Sat, Aug 23
株主統計
種類
株主統計
株主統計
比率
Cotterford Co., Ltd.
11.16%
Lagoda Investment Management, L.P.
10.88%
Armistice Capital LLC
7.89%
Innes (Guy Archibald)
2.68%
Reynolds (Cameron John)
2.02%
他の
65.37%
株主統計
株主統計
比率
Cotterford Co., Ltd.
11.16%
Lagoda Investment Management, L.P.
10.88%
Armistice Capital LLC
7.89%
Innes (Guy Archibald)
2.68%
Reynolds (Cameron John)
2.02%
他の
65.37%
種類
株主統計
比率
Investment Advisor
13.11%
Corporation
12.09%
Hedge Fund
8.10%
Individual Investor
7.33%
Investment Advisor/Hedge Fund
1.04%
Research Firm
0.04%
他の
58.29%
機関投資家保有株
更新時刻: Tue, Jul 1
更新時刻: Tue, Jul 1
報告期間
機関投資家数
保有株式数
比率
変動額
2025Q2
78
41.39M
40.30%
+860.69K
2025Q1
83
44.42M
46.85%
+2.70M
2024Q4
82
41.53M
44.82%
+1.50M
2024Q3
82
38.59M
41.90%
+9.42M
2024Q2
82
28.77M
32.86%
+105.49K
2024Q1
84
28.22M
34.52%
+1.47M
2023Q4
87
26.17M
37.10%
+183.39K
2023Q3
91
25.37M
36.48%
-477.38K
2023Q2
98
25.03M
37.36%
-1.92M
2023Q1
127
25.94M
45.68%
-639.07K
詳細を見る
株主動向
会社名
保有株式数
比率
変動額
変動率
日付
Cotterford Co., Ltd.
12.01M
11.65%
--
--
Apr 25, 2025
Lagoda Investment Management, L.P.
10.19M
9.89%
+2.62M
+34.56%
Mar 31, 2025
Armistice Capital LLC
8.21M
7.97%
-275.46K
-3.25%
Mar 31, 2025
Innes (Guy Archibald)
2.81M
2.72%
+20.00K
+0.72%
Jun 03, 2025
Reynolds (Cameron John)
1.88M
1.83%
+12.50K
+0.67%
Jun 12, 2025
The Vanguard Group, Inc.
706.06K
0.69%
+69.39K
+10.90%
Mar 31, 2025
Concord International Inc.
1.01M
0.98%
--
--
Apr 25, 2025
Geode Capital Management, L.L.C.
761.95K
0.74%
+18.11K
+2.43%
Mar 31, 2025
Micallef (Jacob Vincent)
456.18K
0.44%
-21.53K
-4.51%
Jun 01, 2025
BlackRock Institutional Trust Company, N.A.
445.19K
0.43%
--
--
Mar 31, 2025
詳細を見る
関連ETF
銘柄名
比率
データなし
配当金
過去5年間の配当金総支払額は
0.00
米ドルである。
日付
配当金
権利確定日
支払日
配当落ち日
データなし
株式分割
日付
種類
比率
データなし
日付
種類
比率
データなし
